| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vincerx Pharma, Inc. (VINC) has 0 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. VINC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | Hamdy Ahmed Md | Chief Executive Officer | Buy | 7,830 | $12.77 | $99,989.10 | New | |
| Jun 29, 2021 | Seelenberger Alexander A. | Chief Financial Officer | Buy | 7,950 | $12.61 | $100,259.84 | New | |
| Jun 29, 2021 | Thomas Tom C | See Remarks | Buy | 2,000 | $12.58 | $25,160.00 | New | |
| Jun 29, 2021 | Lee John H. | Director | Buy | 799 | $12.72 | $10,159.29 | New | |
| Jun 29, 2021 | McDonald Andrew I | Director | Buy | 20,000 | $12.38 | $247,600.00 | New |